SEC Semiannual Reporting Rule: Due Diligence Moat Widens
The SEC's proposed shift to semiannual corporate disclosure advances to White House review, creating structural information advantages for sophisticated investors with proprietary research systems and direct issuer relationships.
March 31, 2026
Series B Enterprise AI Funding: Insight Partners Pattern
Wonderful's $150 million Series B from Insight Partners demonstrates how enterprise AI platforms with global deployment infrastructure compress traditional funding timelines, shifting focus from model architecture to go-to-market infrastructure.
March 31, 2026
Space-Based Solar Power Startup Funding 2026
Luxembourg-based TerraSpark secured €5M in pre-seed funding for space-based solar power and wireless energy transmission, signaling a major shift in deep tech startup funding away from mega-funds toward angel syndicates and micro-VCs.
March 31, 2026
Biosimilar Genetic Engineering Venture Capital 2026
Biosimilar genetic engineering startups are attracting unprecedented venture capital in 2026 by securing commercial partnerships before FDA approval, shifting away from traditional decade-long drug discovery cycles.
March 31, 2026
Retail Real Estate Fund Australian Investors 2026
Australian superannuation funds committed $330 million to Nuveen Real Estate's U.S. Cities Retail Fund in March 2026, marking the largest allocation into U.S. necessity-based retail from the region. The Retail Employees Superannuation Trust anchored the raise with a $250 million commitment.
March 31, 2026
Family Office Private Equity Fund 2026: Pritzker's $385M Close
Pritzker Alternative Strategies closed a $385 million private equity fund in March 2026, investing in technology and healthcare deals. This marks a structural shift where single-family offices compete directly with traditional VC/PE funds using smaller, flexible capital.
March 31, 2026
Family Office Private Equity Fund 2026: Pritzker Close
Pritzker Alternative Strategies closed a $385 million private equity fund targeting tech and healthcare. Learn why family offices now outpace institutional PE with faster capital deployment and discretionary decision-making.
March 31, 2026
Biosimilar Genetic Engineering Startup Funding 2026
Neion Bio's emergence from stealth with multi-product biosimilar partnerships signals a fundamental shift in how genetic engineering startups approach funding, prioritizing commercial validation over traditional venture milestones.
March 30, 2026
Defense Aerospace Manufacturing PE Acquisitions Heat Up in 2026
Middle-market PE firms are rotating capital into defense and aerospace manufacturing at the fastest rate since 2001-2003, with deals like Chimney Rock's acquisition of United Electronics signaling a shift away from compressed software multiples.
March 30, 2026
SEC Crypto Asset Regulation: March 17 Framework Explained
The SEC and CFTC issued a joint interpretation on March 17, 2026 establishing the first formal classification framework for crypto assets under federal law, clarifying that most crypto assets are not securities.
March 30, 2026
Retail Real Estate Fund Institutional Capital 2026
Nuveen Real Estate raised $330 million for its U.S. Cities Retail Fund from Australian superannuation funds in March 2026, signaling institutional confidence in necessity-based retail properties anchored by grocery stores.
March 30, 2026
Angel Investor Groups Executive Leadership 2026
Angel Investor Groups Executive Leadership 2026: New York Angels appointed Peter Bodenheimer as Executive Director, signaling a structural transformation toward professionalized angel group management and away from volunteer-led syndicates.
March 30, 2026